What is GYRE's P/E ratio?

GYRE THERAPEUTICS INC. (GYRE) currently trades at a P/E ratio of 150.62.

GYRE THERAPEUTICS INC. reports a Return on Equity (ROE) of -6.21%.

What is GYRE's dividend yield?

GYRE THERAPEUTICS INC. offers a dividend yield of 0.00%.

What is GYRE's Deepscope Quality Score?

Deepscope rates GYRE's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy GYRE?

Deepscope's AI Timing Score for GYRE is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does GYRE belong to?

GYRE THERAPEUTICS INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu GYRE (NASDAQ) | GYRE THERAPEUTICS INC.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-09 | FS: 2026-03-31)

GYRE

GYRE THERAPEUTICS INC.

US:NASDAQ STOCK Healthcare >> Biotechnology News 97

USD 6.13

0.08 (1.32%) Day Change

Watchlist Portfolio Compare Chart

150.62

P/E

0.01

D/E

-6.2%

ROE

-3.9%

ROA

0.00%

Div Yield

-0.09

PEG

GYRE THERAPEUTICS INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.13 Price 0.08 (1.32%) Day Change	NEWS SCORE: 97

GYRE Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 15) và Thời điểm mua ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	97
Magic Formula Rank by ROA	2823
Magic Formula Rank by ROE	2823
Magic Formula Rank by ROIC	2327
Price	6.13
PBV / Sector	4.46 / 4.71
Earning Per Share	-0.06

PE / Sector	150.62 / 17.58
PEG or PE/Growth / Sector	-0.09 / 0.53
Average 1M Daily Value	0.61 M GREAT
Average 1W Daily Value	0.63 M GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-5.37 / 468.85
NPM Average (%) / Sector	-13.86 / -1,531.69
NPM Change Average (%) / Sector	-1,035.18 / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-3.88 / 31.69
ROA Average (%) / Sector	-13.65 / -353.18
ROA Change Average (%) / Sector	-861.22 / 5,214.65
ROE (%) / Sector	-6.21 / 10.58
ROE Average (%) / Sector	122.04 / 27.64 GREAT
ROE Change Average (%) / Sector	2,585.69 / 2,048.88 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

41%

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	224.93 / 16.49 GREAT
Dividend Change Average (%) / Sector	-96.78 / 3.68

Chi tiết đăng ký

Analyze Date	2026-06-10 09:43:57
Symbol	GYRE
Name	GYRE THERAPEUTICS INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	97.03 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	610.31 / 8,889.42

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 12770 High Bluff Drive, San Diego, CA, United States, 92130

Phone: 858 567 7770

Website: https://www.gyretx.com

Employees: 625

Sector: Healthcare >> Biotechnology

Description: Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. Gyre Therapeutics, Inc. was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.